Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury

37Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: We investigated the neuroprotective properties of levosimendan, a novel inodilator, in an in vitro model of traumatic brain injury.Methods: Organotypic hippocampal brain slices from mouse pups were subjected to a focal mechanical trauma. Slices were treated after the injury with three different concentrations of levosimendan (0.001, 0.01 and 0.1 μM) and compared to vehicle-treated slices. After 72 hrs, the trauma was quantified using propidium iodide to mark the injured cells.Results: A significant dose-dependent reduction of both total and secondary tissue injury was observed in cells treated with either 0.01 or 0.1 μM levosimendan compared to vehicle-treated slices.Conclusion: Levosimendan represents a promising new pharmacological tool for neuroprotection after brain injury and warrants further investigation in an in vivo model. © 2010 Roehl et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Roehl, A. B., Hein, M., Loetscher, P. D., Rossaint, J., Weis, J., Rossaint, R., & Coburn, M. (2010). Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury. BMC Neurology, 10. https://doi.org/10.1186/1471-2377-10-97

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free